Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Sold by Mirae Asset Global Investments Co. Ltd.

Mirae Asset Global Investments Co. Ltd. lowered its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 63.7% during the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 56,540 shares of the pharmacy operator's stock after selling 99,111 shares during the quarter. Mirae Asset Global Investments Co. Ltd.'s holdings in Walgreens Boots Alliance were worth $512,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Scientech Research LLC acquired a new position in Walgreens Boots Alliance in the 2nd quarter valued at $1,215,000. Ariel Investments LLC raised its holdings in Walgreens Boots Alliance by 10.8% in the 2nd quarter. Ariel Investments LLC now owns 2,038,878 shares of the pharmacy operator's stock valued at $24,660,000 after acquiring an additional 198,891 shares during the last quarter. Exchange Traded Concepts LLC acquired a new position in Walgreens Boots Alliance in the 3rd quarter valued at $795,000. Clifford Capital Partners LLC raised its holdings in Walgreens Boots Alliance by 58.4% in the 2nd quarter. Clifford Capital Partners LLC now owns 803,204 shares of the pharmacy operator's stock valued at $9,715,000 after acquiring an additional 296,135 shares during the last quarter. Finally, Cetera Investment Advisers raised its holdings in Walgreens Boots Alliance by 89.8% in the 1st quarter. Cetera Investment Advisers now owns 349,464 shares of the pharmacy operator's stock valued at $7,580,000 after acquiring an additional 165,389 shares during the last quarter. Hedge funds and other institutional investors own 58.59% of the company's stock.

Walgreens Boots Alliance Stock Performance

NASDAQ:WBA remained flat at $9.46 on Friday. 12,190,103 shares of the company's stock were exchanged, compared to its average volume of 25,700,582. The company has a current ratio of 0.68, a quick ratio of 0.37 and a debt-to-equity ratio of 0.67. The stock's 50-day moving average price is $9.20 and its 200-day moving average price is $12.44. The company has a market cap of $8.18 billion, a PE ratio of -0.95, a P/E/G ratio of 1.24 and a beta of 0.68. Walgreens Boots Alliance, Inc. has a one year low of $8.22 and a one year high of $27.05.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last issued its quarterly earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 EPS for the quarter, topping the consensus estimate of $0.36 by $0.03. Walgreens Boots Alliance had a negative net margin of 5.85% and a positive return on equity of 14.23%. The business had revenue of $37.50 billion for the quarter, compared to analysts' expectations of $35.75 billion. During the same quarter last year, the company posted $0.67 earnings per share. The company's quarterly revenue was up 5.9% compared to the same quarter last year. On average, equities analysts predict that Walgreens Boots Alliance, Inc. will post 1.53 EPS for the current year.

Walgreens Boots Alliance Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, December 12th. Shareholders of record on Monday, November 18th will be issued a $0.25 dividend. The ex-dividend date of this dividend is Monday, November 18th. This represents a $1.00 dividend on an annualized basis and a yield of 10.57%. Walgreens Boots Alliance's dividend payout ratio is currently -9.99%.

Wall Street Analyst Weigh In

A number of research firms have recently commented on WBA. Barclays upped their price objective on Walgreens Boots Alliance from $7.00 to $8.00 and gave the stock an "underweight" rating in a report on Wednesday, October 16th. UBS Group upped their price objective on Walgreens Boots Alliance from $9.00 to $10.00 and gave the stock a "neutral" rating in a report on Thursday, October 17th. Jefferies Financial Group dropped their price objective on Walgreens Boots Alliance from $19.00 to $9.00 and set a "hold" rating for the company in a report on Wednesday, October 23rd. Morgan Stanley dropped their price objective on Walgreens Boots Alliance from $9.00 to $7.00 and set an "underweight" rating for the company in a report on Friday, October 11th. Finally, Evercore ISI upped their price objective on Walgreens Boots Alliance from $7.50 to $10.00 and gave the stock an "in-line" rating in a report on Wednesday, October 16th. Four research analysts have rated the stock with a sell rating, nine have issued a hold rating and two have issued a buy rating to the company. According to MarketBeat, Walgreens Boots Alliance presently has an average rating of "Hold" and a consensus price target of $12.88.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.